54 phenotypes from 16 alleles in 21 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Oprm1IAP/Oprm1IAP CXB7/ByJ	decreased thermal nociceptive threshold	J:283389
	impaired behavioral response to morphine	J:283389
Oprm1tm1.1Cgrf/Oprm1tm1.1Cgrf Scn10atm2(cre)Jwo/Scn10a+ involves: 129 * C57BL/6J	abnormal behavioral response to addictive substance	J:207536
	normal behavior/neurological phenotype	J:207536
	normal homeostasis/metabolism phenotype	J:207536
	normal integument phenotype	J:207536
Oprm1tm1.1Jbwa/Oprm1tm1.1Jbwa involves: 129S6/SvEvTac * C57BL/6	enhanced behavioral response to addictive substance	J:101977
Oprm1tm1.2Cgrf/Oprm1tm1.2Cgrf involves: 129 * C57BL/6 * C57BL/6J * SJL	decreased physiological sensitivity to xenobiotic	J:207536
Oprm1tm1Jep/Oprm1+ B6.129S-Oprm1tm1Jep	abnormal operant conditioning behavior	J:101294
	enhanced behavioral response to addictive substance	J:101294
	induced hyperactivity	J:101294
Oprm1tm1Jep/Oprm1+ involves: 129S/SvEv	enhanced behavioral response to anesthetic	J:65217
	impaired behavioral response to anesthetic	J:52952, J:65217
	impaired behavioral response to morphine	J:52952, J:65217
Oprm1tm1Jep/Oprm1tm1Jep B6.129S-Oprm1tm1Jep	abnormal lean body mass	J:147786
	abnormal operant conditioning behavior	J:101294
	enhanced behavioral response to addictive substance	J:101294
	enlarged pancreatic islets	J:147786
	impaired ability to fire action potentials	J:101066
	improved glucose tolerance	J:147786
	increased body weight	J:147786
	increased circulating insulin level	J:147786
	increased insulin secretion	J:147786
	increased pancreas weight	J:147786
	increased percent body fat/body weight	J:147786
	increased total body fat amount	J:147786
	induced hyperactivity	J:101294
Oprm1tm1Jep/Oprm1tm1Jep involves: 129S/SvEv	enhanced behavioral response to anesthetic	J:65217
	impaired behavioral response to anesthetic	J:52952, J:65217
	impaired behavioral response to morphine	J:52952, J:65217
Oprm1tm1Jep/Oprm1tm1Jep Tg(Th-Oprm1)4Jtw/0 involves: 129S/SvEv * C57BL/6 * DBA/2	normal nervous system phenotype	J:151536
Oprm1tm1Jlw/Oprm1tm1Jlw involves: 129P2/OlaHsd	abnormal behavioral response to addictive substance	J:131412
	increased chemically-elicited antinociception	J:131412
Oprm1tm1Kff/Oprm1tm1Kff involves: 129S2/SvPas	abnormal pain threshold	J:36241, J:62551
	decreased behavioral withdrawal response	J:62551
	decreased locomotor activity	J:36241
	impaired behavioral response to anesthetic	J:52952
	impaired behavioral response to morphine	J:36241, J:52952, J:207536
	increased coping response	J:62551
Oprm1tm1Kff/Oprm1tm1Kff involves: 129S2/SvPas * C57BL/6J	abnormal social investigation	J:204731
Oprm1tm1Lex/Oprm1tm1Lex involves: 129S5/SvEvBrd * C57BL/6NTac	decreased chemically-elicited antinociception	J:170718
	decreased physiological sensitivity to xenobiotic	J:170718
	impaired behavioral response to morphine	J:170718
	increased thermal nociceptive threshold	J:170718
Oprm1tm1Loh/Oprm1+ involves: 129P2/OlaHsd	decreased chemically-elicited antinociception	J:47187
	decreased susceptibility to xenobiotic induced morbidity/mortality	J:47187
Oprm1tm1Loh/Oprm1tm1Loh involves: 129P2/OlaHsd	abnormal spatial learning	J:85653
	decreased chemically-elicited antinociception	J:47187
	decreased susceptibility to xenobiotic induced morbidity/mortality	J:47187
	enhanced behavioral response to cocaine	J:107973
	impaired behavioral response to morphine	J:47187, J:107973
Oprm1tm1Loh/Oprm1tm1Loh involves: 129P2/OlaHsd * BALB/c * C57BL/6	abnormal excitatory postsynaptic potential	J:61244
	reduced long-term potentiation	J:61244
Oprm1tm1Loh/Oprm1tm1Loh involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J	abnormal nervous system physiology	J:106367
Oprm1tm1Loh/Oprm1tm1Loh involves: 129P2/OlaHsd * C57BL/6 * DBA/2	abnormal circulating glucose level	J:106857
Oprm1tm1Lyu/Oprm1+ involves: Black Swiss	abnormal bone marrow cell physiology	J:39864
	decreased locomotor activity	J:39864
	impaired behavioral response to morphine	J:39864
	increased splenocyte proliferation	J:39864
	increased vertical activity	J:39864
	reduced male mating frequency	J:39864
Oprm1tm1Lyu/Oprm1tm1Lyu involves: Black Swiss	abnormal bone marrow cell physiology	J:39864
	abnormal common myeloid progenitor cell morphology	J:39864
	asthenozoospermia	J:39864
	decreased chemically-elicited antinociception	J:39864
	decreased litter size	J:39864
	decreased locomotor activity	J:39864
	impaired behavioral response to morphine	J:39864
	increased erythroid progenitor cell number	J:39864
	increased splenocyte proliferation	J:39864
	increased vertical activity	J:39864
	oligozoospermia	J:39864
	reduced male fertility	J:39864
	reduced male mating frequency	J:39864
Oprm1tm1Shlz/Oprm1tm1Shlz involves: C57BL/6	abnormal chemically-elicited antinociception	J:176122
	enhanced behavioral response to morphine	J:176122
	increased chemically-elicited antinociception	J:176122
Oprm1tm1Uhl/Oprm1+ either: B6.129S7-Oprm1tm1Uhl or (involves: 129S7/SvEvBrd)	decreased physiological sensitivity to xenobiotic	J:106256
	decreased susceptibility to xenobiotic induced morbidity/mortality	J:106256
	enhanced conditioned place preference behavior	J:106256
Oprm1tm1Uhl/Oprm1tm1Uhl involves: 129S7/SvEvBrd * C57BL/6J	abnormal pain threshold	J:38597
	decreased susceptibility to xenobiotic induced morbidity/mortality	J:106256
	decreased thermal nociceptive threshold	J:38597
	impaired behavioral response to morphine	J:106256
Oprm1tm1Yxp/Oprm1tm1Yxp involves: 129/Sv * C57BL/6	abnormal intestinal transit time	J:147079
	decreased chemically-elicited antinociception	J:147079
Oprm1tm2.1Loh/Oprm1tm2.1Loh Not Specified	abnormal touch/ nociception	J:81978
Oprm1tm2Loh/Oprm1tm2Loh Not Specified	no abnormal phenotype detected	J:81978
Tg(Th-Oprm1)4Jtw/0 involves: C57BL/6 * DBA/2	normal nervous system phenotype	J:151536